Cogent Biosciences (COGT) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

Net selling: insiders sold $1.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: -$1.7M netNet selling
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 3 cutMore cutting

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about COGT filings

Are insiders buying or selling Cogent Biosciences Inc (COGT) stock?

Net selling: insiders sold $1.7M and bought $0 of COGT stock on the open market in the 90 days to Oct 31, 2026, according to SEC Form 4 filings. $1.7M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Morris, Arlene (Director), who sold $1.7M. The latest filing was on Aug 31, 2026.

Which members of Congress have traded COGT recently?

None. No member of Congress disclosed a COGT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COGT smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on COGT

Lean short2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- Arlene Morris, sold $1.7M, scheduled plan sale, filed Aug 31
Lean short · thin1 sale · $1.7M
1 of 1 on scheduled plans. Form 4 filings.
Politicians
No recent politician filings found
Funds
Lean short1 added · 2 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about COGT filings

Are insiders buying or selling Cogent Biosciences Inc (COGT) stock?

Which members of Congress have traded COGT recently?

None. No member of Congress disclosed a COGT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COGT smart-money data?

Funds

What funds are doing

6 moves · 6 mo

Buys/Adds$29.0MSells/Trims$182.3M

Buys/Adds (1)

AQ
AQR
Q2 2026 13F
$4.1M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (2)

DS
D.E. Shaw
Q2 2026 13F
$36.2M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%
CI
Citadel
Ken Griffin · Q2 2026 13F
$33.1M
trimmed

3 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 3 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 8.0% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.52+7.96% beat

-$0.56 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

Estimated report: Nov 6, 2026, in 6 days

Estimates as of Oct 30, 2026

EPS expected

-$0.55

-$0.64 to -$0.45

Last 30 days

5up1down

Analysts raising estimates

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 10, 2026	-$0.52est. -$0.56	+7.96%beat	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 5, 2026	-$0.53est. -$0.54	+1.88%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Feb 17, 2026	-$0.56est. -$0.51	-10.51%miss	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 7, 2025	-$0.50est. -$0.52	+3.24%beat	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 5, 2025	-$0.53est. -$0.58	+8.62%beat	Not on file	Not on file
Mar 31, 2025Reported May 6, 2025	-$0.52est. -$0.58	+9.05%beat	Not on file	Not on file
Dec 31, 2024Reported Feb 25, 2025	-$0.09est. -$0.58	+84.48%beat	Not on file	Not on file
Sep 30, 2024Reported Nov 12, 2024	-$0.64est. -$0.57	-12.28%miss	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $32.86
52-wk high: $43.73
High: $32.86
52-wk low: $13.78
Low: $31.68
Prev close: $32.23
Mkt cap: $5.55B
ROE: -109.7%
Beta: 0.31
P/S: 861.1x
P/B: 12.0x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $5.5B

Valuation

P/S861.15
P/B11.96

Quality

Operating margin0.0%
ROE-109.7%
ROA-43.8%

Growth

Beta0.31

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

56balanced

20D volatility

40%annualized

52-week range

$31.96

$13.78$43.73

20D support

$27.73recent floor

20D resistance

$32.86recent ceiling

Returns

5D +2.1%20D +1.2%60D -24.4%

Price vs moving averages

SMA20 +4.6%SMA50 -1.7%SMA200 -10.6%

Volume pace

1.03xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 10, 2026

-$0.52est. -$0.56

+7.96%

$0.00Yahoo Finance

No year-ago quarter

Mar 31, 2026May 5, 2026

-$0.53est. -$0.54

+1.88%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Feb 17, 2026

-$0.56est. -$0.51

-10.51%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 7, 2025

-$0.50est. -$0.52

+3.24%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2025Aug 5, 2025

-$0.53est. -$0.58

+8.62%

Not on file

Mar 31, 2025May 6, 2025

-$0.52est. -$0.58

+9.05%

Not on file

Dec 31, 2024Feb 25, 2025

-$0.09est. -$0.58

+84.48%

Not on file

Sep 30, 2024Nov 12, 2024

-$0.64est. -$0.57

-12.28%

Not on file

Cogent Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about COGT filings

Smart money on COGT

Questions about COGT filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 8.0% above what analysts expected.

Estimated report: Nov 6, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cogent Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about COGT filings

Smart money on COGT

Questions about COGT filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 8.0% above what analysts expected.

Estimated report: Nov 6, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cogent Biosciences Inc

Overview

Questions about COGT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Cogent Biosciences Inc

Overview

Questions about COGT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.